Glenn M. Esgro
About Glenn M. Esgro
Glenn M. Esgro serves as the Vice President of Sales at CareMetx, LLC, where he has worked since 2023. With over 25 years of experience in pharmaceutical commercial operations, he has held various leadership roles in sales and market access across multiple companies.
Work at CareMetx
Glenn M. Esgro serves as the Vice President of Sales at CareMetx, LLC, a position he has held since 2023. CareMetx is known for its customizable solutions portfolio, which includes e-services, strategic consultation, and comprehensive Hub operations. Esgro's role involves leveraging technology and data to enhance the access experience for specialty therapies. His experience in pharmaceutical commercial operations supports the company's mission to improve patient access to essential medications.
Previous Experience in Pharmaceuticals
Before joining CareMetx, Glenn Esgro held several significant positions in the pharmaceutical industry. He worked at Currax Pharmaceuticals LLC as Sr. National Accounts Director and later as Sr. Director of Market Access and Strategic Accounts. His tenure at Dey Pharma, L.P. as Director of National Accounts and at Esprit Pharma as VP of Trade contributed to his extensive knowledge in sales and market access. Additionally, he served as EVP of Commercial Operations at RxS LLC and held a director role at Biovail.
Education and Expertise
Glenn Esgro earned a Bachelor of Arts degree in Criminal Justice from the University of Richmond, where he studied from 1986 to 1990. With over 25 years of experience in the pharmaceutical sector, he has developed expertise in commercial operations, sales, market access, national accounts, and trade. His educational background and extensive industry experience enable him to effectively lead sales teams and manage commercial departments focused on brand and specialty products.
Career Timeline
Glenn Esgro's career spans over two decades in various roles within the pharmaceutical industry. He began his career at Biovail from 2004 to 2006, followed by positions at Esprit Pharma, Dey Pharma, and Currax Pharmaceuticals from 2009 to 2022. His transition to CareMetx in 2023 marks a new chapter in his professional journey, where he continues to apply his extensive knowledge and skills in sales and market access.